Use of rituximab in the treatment of Epstein-Barr virus reactivation after allogeneic stem cell transplantation: a retrospective study in 86 patients

被引：0
|
作者：
Auger, S. [1 ]
Mines, M. L. [1 ]
Fegueux, N. [1 ]
Ceballos, P. [1 ]
Segondy, M. [1 ]
Rossi, J. -F. [1 ]
机构：
[1] St Eloi Univ Hosp, Montpellier, France
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [41] Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
    Carpenter, Ben
    Haque, Tanzina
    Dimopoulou, Maria
    Atkinson, Claire
    Roughton, Michael
    Grace, Sarah
    Denovan, Shari
    Fielding, Adele
    Kottaridis, Panagiotis D.
    Griffiths, Paul
    Mackinnon, Stephen
    Emery, Vincent
    Chakraverty, Ronjon
    TRANSPLANTATION, 2010, 90 (05) : 564 - 570
  • [42] Epstein-Barr Virus Related Lymphoproliferations After Stem Cell Transplantation
    Sica, Simona
    Metafuni, Elisabetta
    Bellesi, Silvia
    Chiusolo, Patrizia
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2009, 1 (02)
  • [43] Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes
    Yuhua Ru
    Xiang Zhang
    Tiemei Song
    Yiyang Ding
    Ziling Zhu
    Yi Fan
    Yang Xu
    Aining Sun
    Huiying Qiu
    Zhengming Jin
    Xiaowen Tang
    Yue Han
    Zhengzheng Fu
    Suning Chen
    Xiao Ma
    Feng Chen
    Jia Chen
    Depei Wu
    Bone Marrow Transplantation, 2020, 55 : 1754 - 1762
  • [44] Cytokine Gene Polymorphisms and Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Lin, Ren
    Fan, Zhiping
    Zhao, Ke
    Jiang, Qianli
    Sun, Jing
    Liu, Qifa
    BLOOD, 2015, 126 (23)
  • [45] Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation
    Sanz, Jaime
    Andreu, Rafael
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 677 - 683
  • [46] ASSOCIATION OF HLA POLYMORPHISMS WITH EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Lin, R.
    Fan, Q.
    Yu, S.
    Fan, Z.
    Zhang, Y.
    Huang, F.
    Zhou, H.
    Xuan, L.
    Wu, M.
    Guo, X.
    Dai, M.
    Sun, J.
    Liu, Q.
    HAEMATOLOGICA, 2013, 98 : 372 - 372
  • [47] Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation
    Bordon, Victoria
    Padalko, Elizaveta
    Benoit, Yves
    Dhooge, Catharina
    Laureys, Genevieve
    PEDIATRIC TRANSPLANTATION, 2012, 16 (02) : 144 - 150
  • [48] Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection
    Fujii, N
    Takenaka, K
    Hiraki, A
    Maeda, Y
    Ikeda, K
    Shinagawa, K
    Ashiba, A
    Munemasa, M
    Sunami, K
    Hiramatsu, Y
    Ishimaru, F
    Niiya, K
    Yoshino, T
    Harada, M
    BONE MARROW TRANSPLANTATION, 2000, 26 (07) : 805 - 808
  • [49] Epstein-Barr virus in paediatric stem cell transplantation
    Staehelin, F
    Beutler, D
    Avoledo, P
    Gratwohl, A
    Kühne, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S229 - S229
  • [50] Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation with Cocktail Conditioning Regimen for the Treatment of Pediatric Patients with Chronic Active Epstein-Barr Virus: A Retrospective Observational Study
    Fan, Shifen
    Chen, Jiao
    Liu, Zhouyang
    Xiao, Juan
    Jiang, Fan
    Liu, Xiaomei
    Sun, Yuan
    STEM CELLS AND DEVELOPMENT, 2022, 31 (1-2) : 26 - 31
12345